课题基金 / 基金详情

Identification of Small Molecules with INF-beta Inducing Properties as Anti-Viral Leads

Identification of Small Molecules with INF-beta Inducing Properties as Anti-Viral Leads
鉴定具有 INF-β 诱导特性的小分子作为抗病毒先导药物
批准号:
9360483
负责人:
Ajit Jadhav
金额:
$3.75万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Ajit Jadhav的其他基金

相似基金

相关文献

中文摘要
翻译
在此期间,NCGC致力于进一步确定之前确定的热门歌曲的特征。 作为一个中心,NCGC与NIH和校外调查人员建立并保持了110多个积极的合作,促进了人类疾病整个谱系的药物发现工作。这些努力导致了数十个高通量筛选和许多药物化学活动,以进一步改进筛选命中,为我们的合作者和一般研究社区提供出版物和各种有前途的小分子探针和线索。此外,NCGC还致力于推进多项信息学倡议,以更好地利用现有的药物和疾病目标信息,并向公众提供易于获取的资源,进一步促进人类疾病新疗法的开发。
英文摘要
During this period, the NCGC worked to further characterize previously identified hits. As a center, the NCGC has fostered and maintained over 110 active collaborations with both NIH and extramural investigators, facilitating drug discovery efforts across the entire spectrum of human disease. These efforts have led to dozens of high-throughput screens and a number of medicinal chemistry campaigns to further improve on screening hits, providing our collaborators and the general research community with publications and a variety of promising small molecule probes and leads. In addition, the NCGC has worked to advance a number of informatic initiatives to make better use of existing drug and disease target information and provide the general public with easily accessible resources, further catalyzing the development of new therapies for human disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Irreversible targeting of mammalian thioredoxin reductase 1 (TrxR1) for anticancer therapy
Phenotypic Screening to Identify Regulators of CFTR Localization
Selective inhibitors of citron rho kinase (CIT-K)
A quantitative qRT-PCR screen for activators of TRIB1 expression
海外基金